felbamate 400 MG Oral Tablet
- RxCUI
- 198358
- RxNorm name
- felbamate 400 MG Oral Tablet
- Display name
- felbamate 400 MG Oral Tablet
- Full name
- felbamate 400 MG Oral Tablet
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:02
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Felbamate | FELBAMATE | Sun Pharmaceutical Industries, Inc. | f2edb3ed-da20-4093-88ea-00fe781e47e0 | 2026-06-03 | Boxed warning, Warnings, Adverse reactions | 198358 |
| Felbamate | FELBAMATE | Amneal Pharmaceuticals of New York LLC | 1aa40de5-c02d-49d6-8722-ed88c40c3ba6 | 2026-04-06 | Boxed warning, Warnings, Adverse reactions | 198358 |
| Felbamate | FELBAMATE | Bryant Ranch Prepack | 6afd77f2-4525-42f4-a4b1-94159c401dd2 | 2026-03-25 | Boxed warning, Warnings, Adverse reactions | 198358 |
| Felbamate | FELBAMATE | Bryant Ranch Prepack | d6eaf094-09e2-480c-bea9-7a2768aad884 | 2026-03-25 | Boxed warning, Warnings, Adverse reactions | 198358 |
| Felbamate | FELBAMATE | Viona Pharmaceuticals Inc | 96f4357c-720c-4651-b638-7b1181531dc5 | 2026-01-29 | Boxed warning, Warnings, Adverse reactions | 198358 |
| Felbamate | FELBAMATE | ANI Pharmaceuticals, Inc. | 17850520-f823-4d05-8f9b-5eadfa68bae2 | 2025-11-07 | Boxed warning, Warnings, Adverse reactions | 198358 |
| Felbatol | FELBAMATE | Viatris Specialty LLC | 2f522701-397a-11de-8a39-0800200c9a66 | 2025-08-15 | Boxed warning, Warnings, Adverse reactions | 198358 |
| Felbamate | FELBAMATE | Amneal Pharmaceuticals LLC | aa3fd2c0-98d6-45f3-81b0-a902526214c6 | 2024-10-10 | Boxed warning, Warnings, Adverse reactions | 198358 |
| Felbamate | FELBAMATE | Zydus Lifesciences Limited | efa55cb2-b625-4392-9ddb-0a8ad8ee58c4 | 2024-08-16 | 198358 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 6afd77f2-4525-42f4-a4b1-94159c401dd2 | felbamate 400 MG Oral Tablet [PSN] · felbamate 400 MG Oral Tablet [SCD] · FELT 400 MG Oral Tablet [SY] | 3 | 106 | Felbamate Tablets USP 400 mg and 600 mg Before prescribing felbamate, the physician should be thoroughly familiar with the details of this prescribing information. FELBAMATE SHOULD NOT BE USED BY PATIENTS UNTIL THERE HAS BEEN A COMPLETE DISCUSSION OF THE RISKS AND THE PATIENT, PARENT, OR GUARDIAN HAS BEEN PROVIDED THE FELBAMATE WRITTEN ACKNOWLEDGEMENT (SEE PATIENT/PHYSICIAN ACKNOWLEDGMENT FORM). | 20260325 |
| d6eaf094-09e2-480c-bea9-7a2768aad884 | felbamate 400 MG Oral Tablet [PSN] · felbamate 400 MG Oral Tablet [SCD] · FELT 400 MG Oral Tablet [SY] | 3 | 102 | Felbamate Tablets USP 400 mg and 600 mg Before prescribing felbamate, the physician should be thoroughly familiar with the details of this prescribing information. FELBAMATE SHOULD NOT BE USED BY PATIENTS UNTIL THERE HAS BEEN A COMPLETE DISCUSSION OF THE RISKS AND THE PATIENT, PARENT, OR GUARDIAN HAS BEEN PROVIDED THE FELBAMATE WRITTEN ACKNOWLEDGEMENT (SEE PATIENT/PHYSICIAN ACKNOWLEDGMENT FORM). | 20260325 |
| 2f522701-397a-11de-8a39-0800200c9a66 | felbamate 400 MG Oral Tablet [PSN] · felbamate 400 MG Oral Tablet [SCD] · FELT 400 MG Oral Tablet [SY] | 3 | 16 | Before Prescribing Felbatol® (felbamate), the physician should be thoroughly familiar with the details of this prescribing information. FELBATOL® SHOULD NOT BE USED BY PATIENTS UNTIL THERE HAS BEEN A COMPLETE DISCUSSION OF THE RISKS AND THE PATIENT, PARENT, OR GUARDIAN HAS BEEN PROVIDED THE FELBATOL WRITTEN ACKNOWLEDGEMENT (SEE PATIENT/PHYSICIAN ACKNOWLEDGMENT FORM). | 20250815 |
| aa3fd2c0-98d6-45f3-81b0-a902526214c6 | felbamate 400 MG Oral Tablet [PSN] · felbamate 400 MG Oral Tablet [SCD] · FELT 400 MG Oral Tablet [SY] | 3 | 12 | FELBAMATE TABLETS, USP 400 mg and 600 mg | 20241010 |
| efa55cb2-b625-4392-9ddb-0a8ad8ee58c4 | felbamate 400 MG Oral Tablet [PSN] · felbamate 400 MG Oral Tablet [SCD] · FELT 400 MG Oral Tablet [SY] | 3 | 6 | Felbamate Tablets, USP | 20240816 |
| f2edb3ed-da20-4093-88ea-00fe781e47e0 | felbamate 400 MG Oral Tablet [PSN] · felbamate 400 MG Oral Tablet [SCD] · FELT 400 MG Oral Tablet [SY] | 3 | 6 | Felbamate Tablets USP 400 mg and 600 mg | 20231215 |
| 17850520-f823-4d05-8f9b-5eadfa68bae2 | felbamate 400 MG Oral Tablet [PSN] · felbamate 400 MG Oral Tablet [SCD] · FELT 400 MG Oral Tablet [SY] | 3 | 5 | Felbamate Tablets USP 400 mg and 600 mg Before prescribing felbamate, the physician should be thoroughly familiar with the details of this prescribing information. FELBAMATE SHOULD NOT BE USED BY PATIENTS UNTIL THERE HAS BEEN A COMPLETE DISCUSSION OF THE RISKS AND THE PATIENT, PARENT, OR GUARDIAN HAS BEEN PROVIDED THE FELBAMATE WRITTEN ACKNOWLEDGEMENT (SEE PATIENT/PHYSICIAN ACKNOWLEDGMENT FORM). | 20251107 |
| 96f4357c-720c-4651-b638-7b1181531dc5 | felbamate 400 MG Oral Tablet [PSN] · felbamate 400 MG Oral Tablet [SCD] · FELT 400 MG Oral Tablet [SY] | 3 | 3 | Felbamate Tablets, USP | 20260129 |
| 1aa40de5-c02d-49d6-8722-ed88c40c3ba6 | felbamate 400 MG Oral Tablet [PSN] · felbamate 400 MG Oral Tablet [SCD] · FELT 400 MG Oral Tablet [SY] | 3 | 3 | Felbamate Tablets, USP (400 mg and 600 mg) Rx only | 20241220 |
| 0a82bcc3-0420-45f5-8c5c-44ab378b4ff3 | felbamate 400 MG Oral Tablet [PSN] · felbamate 400 MG Oral Tablet [SCD] · FELT 400 MG Oral Tablet [SY] | 3 | 1 | Felbamate Tablets | 20150801 |